User profiles for Tianlin He

Tianlin HE

Mosaiques Diagnostics GmbH
Verified email at mosaiques.de
Cited by 205

[HTML][HTML] Role of hypoxia in the tumor microenvironment and targeted therapy

G Chen, K Wu, H Li, D Xia, T He - Frontiers in oncology, 2022 - frontiersin.org
Tumor microenvironment (TME), which is characterized by hypoxia, widely exists in solid
tumors. As a current research hotspot in the TME, hypoxia is expected to become a key element …

Proteomic biomarkers in the cardiorenal syndrome: Toward deciphering molecular pathophysiology

T He, Z Zhang, JA Staessen, H Mischak… - American journal of …, 2021 - academic.oup.com
Cardiorenal syndrome (CRS) is defined by coexisting heart and renal dysfunctions.
Malfunction of 1 organ may cause dysfunction of the other with variable causative disease that …

Prion protein and cancers

X Yang, Y Zhang, L Zhang, T He… - Acta Biochim Biophys …, 2014 - academic.oup.com
The normal cellular prion protein, PrP C is a highly conserved and widely expressed cell
surface glycoprotein in all mammals. The expression of PrP is pivotal in the pathogenesis of …

Urinary peptides in heart failure: a link to molecular pathophysiology

T He, M Mischak, AL Clark, RT Campbell… - European Journal of …, 2021 - Wiley Online Library
Aims Heart failure (HF) is a major public health concern worldwide. The diversity of HF
makes it challenging to decipher the underlying complex pathological processes using single …

[HTML][HTML] Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer

B Zhao, T He - Oncology reports, 2015 - spandidos-publications.com
Chidamide is a newly designed histone deacetylase (HDAC) inhibitor that has been applied
in clinical trials. This study aimed to test the effect of Chidamide on proliferation and …

Peptides in plasma, urine, and dialysate: toward unravelling renal peptide handling

T He, M Pejchinovski, W Mullen, J Beige… - PROTEOMICS …, 2021 - Wiley Online Library
Purpose The peptidomes of spent hemodialysate, urine, and plasma are investigated, to shed
light on peptide handling in the kidney. Experimental Design Fifteen plasma, 15 urine, and …

Gambogic acid inhibits the progression of gastric cancer via circRNA_ASAP2/miR-33a-5p/CDK7 axis

D Lin, X Lin, T He, G Xie - Cancer management and research, 2020 - Taylor & Francis
Background Gastric cancer (GC) is a major cancer-related mortality disease. Gambogic acid
(GA) has been investigated to inhibit cancer progression. In the present study, the molecular …

CD99 and polymeric immunoglobulin receptor peptides deregulation in critical COVID‐19: A potential link to molecular pathophysiology?

J Siwy, R Wendt, A Albalat, T He, H Mischak… - …, 2021 - Wiley Online Library
Identification of significant changes in urinary peptides may enable improved understanding
of molecular disease mechanisms. We aimed towards identifying urinary peptides …

[HTML][HTML] The c-Myc–LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer

TL He, YJ Zhang, H Jiang, X Li, H Zhu, KL Zheng - Medical Oncology, 2015 - Springer
The transcription factor c-Myc plays critical roles in cancer development and progression
through regulating expression of targeted genes. Lactate dehydrogenase A (LDHA), which …

Implementation of proteomics in clinical trials

T He - PROTEOMICS–Clinical Applications, 2019 - Wiley Online Library
The application of protein (or peptide) biomarkers in clinical studies is a dynamic, ever‐growing
field. The introduction of clinical proteomics/peptidomics, such as mass spectrometry–…